FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 18:32:09 09/05/2024 BST | ||
| 1.66 EUR | -9.78% |
|
| Current month | -34.29% | ||
| 1 month | -37.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/05/24 | 1.66 | -9.78% | 0 |
| 08/05/24 | 1.84 | -4.17% | 0 |
| 07/05/24 | 1.92 | +0.52% | 0 |
| 06/05/24 | 1.91 | +16.46% | 0 |
| 03/05/24 | 1.64 | -39.93% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 09, 2024 at 06:32 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK8UR2 |
| ISIN | DE000UK8UR25 |
| Date issued | 28/10/2022 |
| Strike | 409.7 $ |
| Maturity | Unlimited |
| Parity | 53 : 1 |
| Emission price | 5.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.86 € |
|---|---|
| Lowest since issue | 1.45 € |
| Spread | 0.05 € |
| Spread % | 2.92% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.3
USD
Average target price
313.3
USD
Spread / Average Target
+1.95%
- Stock Market
- Certificates
- Certificat
